Patients with hypertension: 3 trials - ALLHAT (amlodipine vs chlor, diabetic subgroup) - IDNT (amlodipine vs PBO) - FACET
Patients with or without hypertension: 3 trials - ALLHAT (amlodipine vs chlor, diabetic subgroup) - IDNT (amlodipine vs PBO) - FACET
1 trials - IDNT (amlodipine vs PBO)
7 trials - PRAISE II - Ghali - Binkley - PRAISE - Udelson - Smith - Packer
All type of patient: 6 trials - ACCOMPLISH - ASCOT-BPLA - AASK (amlodipine vs metoprolol) - ALLHAT (CCB vs ACEI) - ALLHAT (CCB vs diu) - IDNT (amlodipine vs pbo)
Diabetic patients : 4 trials - ALLHAT (amlodipine vs chlor, diabetic subgroup) - ALLHAT (CCB vs ACEI) - IDNT (amlodipine vs PBO) - FACET
Nephropathy: 2 trials - AASK (amlodipine vs metoprolol) - IDNT (amlodipine vs pbo)
Patients undergoing dialysis : 1 trials - Tepel et al
Patients with additional risk factor: 4 trials - ACCOMPLISH - ASCOT-BPLA - ALLHAT (CCB vs ACEI) - ALLHAT (CCB vs diu)